Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026)

Abeona Therapeutics (ABEO) recorded quarterly Raw Materials of $5.5 million in Q1 2026, little changed quarter-over-quarter from $5.5 million in Q4 2025.

Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026) Analysis & Trends

Abeona Therapeutics' Raw Materials history runs 2 years deep, the most recent figure standing at $5.5 million for Q1 2026.

  • In Q1 2026, Raw Materials changed N/A year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
  • Raw Materials was $5.5 million for Q1 2026 at Abeona Therapeutics, roughly flat from $5.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.5 million in Q1 2026 to a low of $5.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Abeona Therapeutics 309.15 Mn 140.88 Mn 6.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.50 Mn
Dec 31, 2025 5.49 Mn